Firm-level Exposure to Epidemic Diseases: Covid-19, SARS, and H1N1
Authors
Abstract
We construct text-based measures of the primary concerns listed firms associated with the spread of COVID-19 and other epidemic diseases. We identify which firms perceive to lose or gain from a given epidemic and textually decompose the epidemic’s effect on the firm’s demand and supply. We find that the effects of COVID-19 manifest as a simultaneous shock to demand and supply, with both shocks affecting firms’ market valuations in equal measure on average. By contrast, demand-related impacts appear more important in accounting for the observed collapse in firm-level investment during the COVID-19 crisis.
To cite this article
Hassan, T., Hollander, S., van Lent, L., & Tahoun, A. (2023). Firm-level exposure to epidemic diseases: Covid-19, SARS, and H1N1. Review of Financial Studies, 36(12), 4919–4964. https://doi.org/10.1093/rfs/hhad044